Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility

Figure 3

Expression of CXCR2 in human tissues and various cancers. The expression of CXCR2 was downregulated in BLCA, lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSC), lung adenocarcinoma (LUAD), skin cutaneous melanoma (SKCM), and thymoma (Thymoma) (b) subjects. Nevertheless, CXCR2 expression was augmented in patients with acute myeloid leukemia (LAML).

(a)

(b)